A chemical with potential 

 
 

Mary Skelly, CEO first filed a patent for the technology in 2008. A year later, following successful antimicrobial tests on bacteria and spores, she decided to trial it on mosquitoes.

The formula was tested on Anopheles arabiensis, one of the mosquito species that carries malaria, and Aedes aegypti, the major culprit in Zika transmission. The results showed that the micellized aldehyde solutions were highly effective at killing the immature stages of both species of mosquito.

The complexed aldehydes have also outperformed non-complexed market leaders in head-to-head studies of hospital high level disinfectants.

The true advantage is the environmentally friendly nature of the solution. The product is entirely biodegradable – after use it breaks down into CO2 and water.

The Microbide solutions are pH neutral and studies show the active aldehydes have no effect on larger organisms found in water, such as fish, plants and even adult mosquitoes.

 

There is an urgent need for better disinfection and bio-hazard control options that can address a broad range of bio-safety challenges occurring around the globe. 

Microbide hopes to reduce HAI (Hospital Acquired Infections) with their Microbide-HLD (High Level Disinfectant) range of products, used for cleaning invasive medical equipment such as endoscopes, surgical equipment and hard surface cleaners.

Microbide has joined the fight to reduce vector-borne diseases such as Zika Virus, Dengue Fever and Malaria carried by mosquitos by creating a solution that is highly effective at killing mosquito larvae and trialling it's effectiveness in Pune and Goa (India).

Microbide is also in working to combat Avian Influenza (AI) and other such disease that effect our food supply. AI poses potential threats to human health as AI viruses have previously transmitted across species to humans.  Current testing has proved successful with the two strains of avian flu, H5N1 and H9N2.

 

4 million

 patients in the European Union suffer at least one HAI (Hospital Acquired Infection) annually, contributing to 110,000 deaths

OECD


17%

of all infectious disease are vector borne diseases, causing more than 700,000 deaths annually

WHO


400,000

Deaths every year globally from Malaria

WHO


96 million

estimated cases of Dengue Fever per year

WHO